Correlation Between 4D Molecular and Esperion Therapeutics

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both 4D Molecular and Esperion Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining 4D Molecular and Esperion Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between 4D Molecular Therapeutics and Esperion Therapeutics, you can compare the effects of market volatilities on 4D Molecular and Esperion Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in 4D Molecular with a short position of Esperion Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of 4D Molecular and Esperion Therapeutics.

Diversification Opportunities for 4D Molecular and Esperion Therapeutics

-0.71
  Correlation Coefficient

Pay attention - limited upside

The 3 months correlation between FDMT and Esperion is -0.71. Overlapping area represents the amount of risk that can be diversified away by holding 4D Molecular Therapeutics and Esperion Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Esperion Therapeutics and 4D Molecular is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on 4D Molecular Therapeutics are associated (or correlated) with Esperion Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Esperion Therapeutics has no effect on the direction of 4D Molecular i.e., 4D Molecular and Esperion Therapeutics go up and down completely randomly.

Pair Corralation between 4D Molecular and Esperion Therapeutics

Given the investment horizon of 90 days 4D Molecular Therapeutics is expected to under-perform the Esperion Therapeutics. In addition to that, 4D Molecular is 1.18 times more volatile than Esperion Therapeutics. It trades about -0.13 of its total potential returns per unit of risk. Esperion Therapeutics is currently generating about 0.06 per unit of volatility. If you would invest  224.00  in Esperion Therapeutics on September 1, 2024 and sell it today you would earn a total of  56.00  from holding Esperion Therapeutics or generate 25.0% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthWeak
Accuracy100.0%
ValuesDaily Returns

4D Molecular Therapeutics  vs.  Esperion Therapeutics

 Performance 
       Timeline  
4D Molecular Therapeutics 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days 4D Molecular Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's primary indicators remain comparatively stable which may send shares a bit higher in December 2024. The newest uproar may also be a sign of mid-term up-swing for the firm private investors.
Esperion Therapeutics 

Risk-Adjusted Performance

12 of 100

 
Weak
 
Strong
Good
Compared to the overall equity markets, risk-adjusted returns on investments in Esperion Therapeutics are ranked lower than 12 (%) of all global equities and portfolios over the last 90 days. Even with relatively weak basic indicators, Esperion Therapeutics reported solid returns over the last few months and may actually be approaching a breakup point.

4D Molecular and Esperion Therapeutics Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with 4D Molecular and Esperion Therapeutics

The main advantage of trading using opposite 4D Molecular and Esperion Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if 4D Molecular position performs unexpectedly, Esperion Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Esperion Therapeutics will offset losses from the drop in Esperion Therapeutics' long position.
The idea behind 4D Molecular Therapeutics and Esperion Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Competition Analyzer module to analyze and compare many basic indicators for a group of related or unrelated entities.

Other Complementary Tools

Performance Analysis
Check effects of mean-variance optimization against your current asset allocation
Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency
Money Flow Index
Determine momentum by analyzing Money Flow Index and other technical indicators
Price Transformation
Use Price Transformation models to analyze the depth of different equity instruments across global markets
Top Crypto Exchanges
Search and analyze digital assets across top global cryptocurrency exchanges